Informações:
Falhas:
ID
34324
Descrição
Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience; ODM derived from: https://clinicaltrials.gov/show/NCT02485262
Link
https://clinicaltrials.gov/show/NCT02485262
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C NCT02485262
Eligibility Hepatitis C NCT02485262
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C NCT02485262
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
adult chronic hcv patients aged >18
boolean
ID.2
Item
treatment naïve
boolean
ID.3
Item
patient with cirrhosis and no cirrhosis. cirrhosis defined as stage 4 fibrosis on liver biopsy or fibro sure results indicating cirrhosis or has clinical findings suggestive of cirrhosis
boolean
ID.4
Item
patients meet the indication to receive one of the sof treatment based regimens
boolean
ID.5
Item
co-infected patients with hiv or hepatitis b
boolean
ID.6
Item
patient received one of the daas regimens
boolean
ID.7
Item
patient with active substance abuse and alcohol abuse
boolean
ID.8
Item
patient received prior daa regimen
boolean
ID.9
Item
decompensated cirrhotic patients
boolean
ID.10
Item
patient has contraindication to receive sof
boolean